Zhu et al. (Zhu et al., 2020), who included 193 PC patients from nine studies, demonstrated that parafibromin immunonegativity might be used to reflect the risk of recurrence, metastasis, and death in PC. The gene discussed is CDC73; the disease is pachyonychia congenita.